II
ICPT

Inspire Investing’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Inspire Investing’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-31,868
Closed -$473K – 815
2021
Q3 		$473K Buy
+31,868
New +$510K 0.06% 225
2020
Q2 		– Sell
-2,662
Closed -$168K – 752
2020
Q1 		$168K Buy
2,662
+821
+45% +$73.8K 0.07% 498
2019
Q4 		$228K Sell
1,841
-1,308
-42% -$117K 0.08% 233
2019
Q3 		$209K Buy
+3,149
New +$211K 0.08% 271
2018
Q1 		– Sell
-917
Closed -$54K – 760
2017
Q4 		$54K Buy
+917
New +$57.8K 0.05% 703

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Inspire Investing's ICPT Position: Q4 2021 in Review

Inspire Investing sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2021, closing a stake of 31,868 shares — an estimated $473K sold.

Inspire Investing first reported a position in ICPT in Q4 2017 and held it in 5 quarters. The position peaked at $473K in Q3 2021. 147 funds tracked by Wall St. Rank hold ICPT as of Q4 2021.

  • Inspire Investing reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Inspire Investing sold 31,868 Intercept Pharmaceuticals, Inc. shares in Q4 2021, an estimated $473K.
  • Inspire Investing first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and held it in 5 quarters.
  • Inspire Investing's Intercept Pharmaceuticals, Inc. position peaked at $473K in Q3 2021.
  • 147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2021.

Based on Inspire Investing's 13F filing for Q4 2021, filed 3 Feb 2022.